In 1992 Frazier was hired as the general counsel of Astra Merck Group, a joint venture in charge of marketing the heartburn drug Prilosec.
FORBES: Merck Could Return To Greatness If CEO Can Leave His Own Past Behind
Patients on this vegetarian diet for four weeks reduced their bad cholesterol levels just as much as a control group on Merck's Mevacor.
He said there was another group of drugs, led by Merck's Raltegravir which are also targeted at this group of patients, but which stop HIV integrating into cells.
Timothy Anderson, an analyst at Prudential Equity Group who is neutral on Merck shares, wrote in a note to investors that the decision was on balance a negative for Merck.
Now chief executive of the Pharmaceutical Research and Manufacturers of America, the industry group for Big Pharma companies like Merck and Novartis.
In a note to investors last week, Prudential Equity Group analyst Timothy Anderson wrote that Merck Chief Executive RichardClarkRichard Clark says Vioxx doesn't keep him up at night.
In a note to investors last week, Prudential Equity Group analyst Timothy Anderson wrote that Merck Chief Executive Richard Clark says Vioxx doesn't keep him up at night.
However, dogs primarily catch the virus while in close quarters with other dogs that are coughing and sneezing, says Steven Shell, head of Merck's U.S. companion animal group.
But while many of these drugs have run into delays, drugs with other other approaches like Accomplia from Sanofi-Aventis or a similar, unnamed medicine that Timothy Anderson at Prudential Equity Group says may be being developed at Merck, have been speeding along.
In 4S, after five years, patients on simvastatin (trade name: Zocor, Merck) had mean decreases of 35% for LDL and 30% fewer deaths than the placebo group.
FORBES: Do We Really Need Head-To-Head Comparison Trials With Statins To Improve Cardiac Health?
Giusti founded an advocacy group, the Multiple Myeloma Research Foundation, that works with companies like Novartis, Celgene, and Merck to develop new treatments.
Timothy Anderson, an analyst at Prudential Equity Group, predicts the result will at the least hurt Avandia sales as patients switch to competing medicines from Merck and Takeda.
Timothy Anderson, an analyst at Prudential Equity Group, predicts the result will at the least hurt Avandia sales as patients switch to competing medicines from Merck (nyse: MRK - news - people ) and Takeda.
应用推荐